Short description
Impact Biomedicines is pioneering the development of life-changing treatments for patients.
Description
Impact Biomedicines is pioneering the development of life changing treatments for patients with complex cancers. The Company’s pipeline is centered around fedratinib, a potent and highly selective oral small molecule JAK2 kinase inhibitor that is being developed initially for the treatment of myelofibrosis and polycythemia vera.
Last funding
Noaccess
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
San Diego, California, United States, North America
Founded on
January 1, 2016
Exited on
January 7, 2018
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$56378 - 90123
Sign in for full access
Investors
Cannot Access, No Way
Sign in for full access
Founders
Catriona Jamieson, Charles McDermott, John Hood